Le Lézard
Classified in: Health
Subjects: TDS, FDA, FVT

OrthoFXtm Receives FDA Clearance for NiTimetm Aligners


FREMONT, Calif., April 17, 2023 /PRNewswire/ -- OrthoFX, a pioneer in the next generation of orthodontic aligners, today announced the U.S Food and Drug Administration (FDA) 510(k) clearance of their NiTime Aligners. OrthoFX's NiTime Aligner is the first aligner system that is explicitly designed for overnight wear. OrthoFX will exhibit NiTime Aligners at the American Association of Orthodontists Annual Meeting in Chicago at booth #641.

OrthoFXtm Receives FDA Clearance for NiTimetm Aligners

About NiTime Aligners:

Loc Phan, Co-founder and VP of Research and Development said "Our team of experts has worked tirelessly to create a solution effective for nighttime only wear. The ability to wear the aligners at night while patients sleep ? makes the treatment journey much easier. The introduction of NiTime Aligner marks a significant milestone in our commitment to providing unique innovations to our doctors and their patients."

NiTime Aligners will be available starting April 21st, 2023 to a limited initial group of orthodontic practices. For more information visit the OrthoFX booth at AAO or click here. OrthoFX will exhibit their full line of proprietary, patented polymer innovations including Rescue and Bright Alignerstm at AAO, booth #641.

About OrthoFX: The company was founded by a team of industry experts who played a critical role in building and scaling the clear aligner category. OrthoFX is pioneering next generation advancements in orthodontics and dental treatments through innovations in polymers, software and services. Learn more about our innovations and services here . You can also sign up as a provider here.

Contact:
Dwight Schnaitter ? Vice President of Commercialization, OrthoFXtm
Email - [email protected]

SOURCE OrthoFX


These press releases may also interest you

at 09:05
Smart Meter, the leading supplier of Cellular Remote Patient Monitoring (RPM)tm solutions, has introduced a new version of the iGlucose, its patented cellular-connected glucose meter used by over 200,000 people with diabetes since 2019. The...

at 09:00
Today, the Honourable Gary Anandasangaree, Minister of Crown-Indigenous Relations; the Honourable Patty Hajdu, Minister of Indigenous Services and Minister responsible for FedNor; the Honourable Dan Vandal, Minister of Northern Affairs; and the...

at 08:05
GE HealthCare today unveiled SIGNA MAGNUS, an FDA 510(k) pending head-only magnetic resonance (MR) scanner designed to explore advancements in neuroscience, which have been restricted by the performance limitations of conventional whole-body MR...

at 07:00
To mark National Hospice Palliative Care Week, the Quebec Coalition for Palliative Care Access (the Coalition) is proud to celebrate the positive impact of palliative care on the well-being of people with life-limiting illness. Palliative care is...

at 06:00
A native born and trained Brazilian oncologist is in the forefront of a new era in the treatment of cancer patients with cutting edge proton therapy medical technology developed in Israel by P-Cure. "It is my dream to be able to bring the P-Cure...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...



News published on and distributed by: